Stock Market News
Concepta scores distribution deal with Chinese pharma titan
(WebFG News) - Women's healthcare company Concepta said on Thursday that it has signed a contract with SinoPharm for the stock holding and distribution logistics for the Chinese market.
The distribution agreement will see SinoPharm, the largest state-owned pharmaceutical company in China, coordinate the logistics of deliveries of myLotus monitors with Concepta's China office.
MyLotus monitors were developed by Concepta to help women pinpoint their ovulation so as to assist with conception.
Erik Henau, chief executive of Concepta, said: "The deal offers us greater flexibility in the Chinese market as stock will be readily available rather than having to be manufactured to order. This will facilitate the development of sales across the provinces and enable the Company to focus on securing repeat business."
The agreed contract with SinoPharm will run to 31 December 2018 and be renewed on a yearly basis.
"It is a strong endorsement of the quality of our products that Concepta is able to engage with organisations of SinoPharm's stature. They have a strong ongoing programme of working with foreign companies and this relationship is reflective of the focus we now have of working with targeted partners in China," said Henau.
In markedly less positive news, the company reported that a previously announced order from ShanDong WeiHai HaiChen Pharmaceutical has not been completed as "payments have not been forthcoming and will no longer be relied upon."
Going forward, Concepta aims to establish links with a number of 'gold' distributors who will introduce myLotus to the market before distribution expands more broadly.
As of 1044 BST, Concepta PLC's shares were up 22.91% at 7.68p.
The distribution agreement will see SinoPharm, the largest state-owned pharmaceutical company in China, coordinate the logistics of deliveries of myLotus monitors with Concepta's China office.
MyLotus monitors were developed by Concepta to help women pinpoint their ovulation so as to assist with conception.
Erik Henau, chief executive of Concepta, said: "The deal offers us greater flexibility in the Chinese market as stock will be readily available rather than having to be manufactured to order. This will facilitate the development of sales across the provinces and enable the Company to focus on securing repeat business."
The agreed contract with SinoPharm will run to 31 December 2018 and be renewed on a yearly basis.
"It is a strong endorsement of the quality of our products that Concepta is able to engage with organisations of SinoPharm's stature. They have a strong ongoing programme of working with foreign companies and this relationship is reflective of the focus we now have of working with targeted partners in China," said Henau.
In markedly less positive news, the company reported that a previously announced order from ShanDong WeiHai HaiChen Pharmaceutical has not been completed as "payments have not been forthcoming and will no longer be relied upon."
Going forward, Concepta aims to establish links with a number of 'gold' distributors who will introduce myLotus to the market before distribution expands more broadly.
As of 1044 BST, Concepta PLC's shares were up 22.91% at 7.68p.
Related share prices |
---|
Concepta (CPT) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price